We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Stealth today announced that it has joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering rare disease treatments for the patients they collectively serve.
Approximately 20 million Americans suffer from Dry Eye Disease – the itchy, uncomfortable and inconvenient condition that remains the number one reason for ophthalmologist visits.